BioLineRx Ltd. Finance Income
BioLineRx Ltd. (BLRX) reported Finance Income of $1.46 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Other Income
ifrs-full:FinanceIncome · last filed 2026-03-23
- BioLineRx Ltd. finance income for the quarter ending 2025-06-30 was $490.00K, a 8.41% decline year-over-year.
- BioLineRx Ltd. finance income for the quarter ending 2024-06-30 was $535.00K, a 21.59% increase year-over-year.
- BioLineRx Ltd. finance income for the quarter ending 2023-06-30 was $440.00K, a 450.00% increase year-over-year.
- BioLineRx Ltd. finance income for the quarter ending 2022-06-30 was $80.00K, a 38.46% decline year-over-year.
| Period end | Finance Income 3 month | Finance Income 6 month | Finance Income 12 month |
|---|---|---|---|
| 2025-12-31 | $1.46M 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $490.00K 6-K · filed 2025-08-14 | $784.00K 6-K · filed 2025-08-14 | |
| 2024-12-31 | $1.87M 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $535.00K 6-K · filed 2025-08-14 | $1.10M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $2.07M 20-F · filed 2026-03-23 | ||
| 2023-06-30 | $440.00K 6-K · filed 2024-08-15 | $977.00K 6-K · filed 2024-08-15 | |
| 2022-12-31 | $694.00K 20-F · filed 2025-03-31 | ||
| 2022-06-30 | $80.00K 6-K · filed 2023-08-30 | $147.00K 6-K · filed 2023-08-30 | |
| 2021-12-31 | $559.00K 20-F · filed 2024-03-26 | ||
| 2021-06-30 | $130.00K 6-K · filed 2022-08-16 | $247.00K 6-K · filed 2022-08-16 | |
| 2020-12-31 | $236.00K 20-F · filed 2023-03-22 | ||
| 2020-06-30 | $35.00K 6-K · filed 2021-08-18 | $175.00K 6-K · filed 2021-08-18 | |
| 2019-12-31 | $777.00K 20-F · filed 2022-03-16 | ||
| 2019-06-30 | $171.00K 6-K · filed 2020-08-06 | $381.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | $719.00K 20-F · filed 2021-02-23 | ||
| 2018-06-30 | $287.00K 6-K · filed 2019-08-06 | $462.00K 6-K · filed 2019-08-06 | |
| 2017-12-31 | $1.17M 20-F · filed 2020-03-12 | ||
| 2017-06-30 | $304.00K 6-K · filed 2018-08-13 | $761.00K 6-K · filed 2018-08-13 | |
| 2016-12-31 | $480.00K 20-F · filed 2019-03-28 | ||
| 2015-12-31 | $457.00K 20-F · filed 2018-03-06 |